2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea

다국어 초록 (Multilingual Abstract)

As in other countries, type 2 diabetes is major health concern in Korea. A dramatic increase in the prevalence of type 2 diabetes and its chronic complications has led to an increase in health costs and economic burdens. Early detection of high risk individuals,hidden diabetic patients, and improvement in the quality of care for the disease are the first steps to mitigate the increase in prevalence. The Committee of Clinical Practice Guidelines of the Korean Diabetes Association revised and updated the ‘3rd Clinical Practice Guidelines’ at the end of 2010. In the guidelines, the committee recommended active screening of high risk individuals for early detection and added the hemoglobin A1c level to the diagnostic criteria for type 2 diabetes based on clinical studies performed in Korea. Furthermore, the committee members emphasized that integrating patient education and self-management is an essential part of care. The drug treatment algorithm based on the degree of hyperglycemia and patient characteristics were also updated.

참고문헌 (Reference)

1 배지철, "서울의 한 대학병원에서 당뇨병을 예측하는 당화혈색소 값의 분석" 대한당뇨병학회 33 (33): 503-510, 2009

2 김진화, "나주지역 중년인구에서 공복혈당을 통한 당뇨병 진단의 적절성 평가" 대한당뇨병학회 32 (32): 328-337, 2008

3 Oh JY, "The diagnosis of diabetes mellitus in Korea: a pooled analysis of four community-based cohort studies" 24 : 217-218, 2007

4 김대중, "The Epidemiology of Diabetes in Korea" 대한당뇨병학회 35 (35): 303-308, 2011

5 "Statistics Korea: 2009 statistical results about cause of death"

6 American Diabetes Association, "Standards of medical care in diabetes--2010" 33 : 11-61, 2010

7 Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus, "Report of Task Force Team for Basic Statistical Study of Korean Diabetes Mellitus: diabetes in Korea 2007. 1st ed" Goldfishery 2007

8 Ohkubo Y, "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study" 28 : 103-117, 1995

9 Skyler JS, "Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association" 32 : 187-192, 2009

10 UK Prospective Diabetes Study (UKPDS) Group, "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)" 352 : 837-853, 1998

11 Yoon KH, "Epidemic obesity and type 2 diabetes in Asia" LANCET LTD 368 : 1681-1688, 200611

12 UK Prospective Diabetes Study (UKPDS) Group, "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)" 352 : 854-865, 1998

13 Kim KS, "Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects" 25 : 997-1000, 2008

14 Ku YH, "Diagnostic value of HbA1c different clinical setting with different prevelence of diabetes mellitus" 32 (32): S311-, 2008

15 Choi KM, "Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans" 19 : 853-857, 2002

16 Kim DJ, "Clinical characteristics of Korean type 2 diabetic patients in 2005" 77 : 252-257, 2007

17 Choi YH, "Classification of diabetes mellitus according to NDDG and ADA diagnostic criteria and comparison of insulin secretion" 23-24, 1998

18 Song J, "Annual report on external quality assessment in metabolic disorders in Korea (2008)" 31 : 143-159, 2009

19 Oh JY, "A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies" Elsevier Scientific Publishers 80 (80): 463-468, 200803

20 Hanas R, "2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement" 33 : 1903-1904, 2010